Barry S Levy, MD in Sherborn, MA - Preventive Medicine

Barry S Levy, MD is a Preventive Medicine - Occupational Medicine physician based in Sherborn, Massachusetts. Barry S Levy is licensed to practice in Massachusetts (license number 35399) and his current practice location is 20 N Main St, #200, Sherborn, Massachusetts. He can be reached at his office (for appointments etc.) via phone at (508) 650-1039.

NPI number for Barry S Levy is 1316062193 and his current mailing address is Po Box 1230, Sherborn, Massachusetts. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1316062193.

Contact Information

	Barry S Levy, MD
	20 N Main St, #200, Sherborn, MA 01770-1500
	(508) 650-1039
	Not Available

Physician's Profile

Full Name	Barry S Levy
Gender	Male
Speciality	Preventive Medicine - Occupational Medicine
Location	20 N Main St, Sherborn, Massachusetts
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1316062193
Provider Enumeration Date: 03/20/2007
Last Update Date: 07/08/2007

Medical Identifiers

Medical identifiers for Barry S Levy such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1316062193	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
2083X0100X	Preventive Medicine - Occupational Medicine	35399 (Massachusetts)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Barry S Levy is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Barry S Levy, MD Po Box 1230, Sherborn, MA 01770-7230 Ph: (508) 650-1039	Barry S Levy, MD 20 N Main St, #200, Sherborn, MA 01770-1500 Ph: (508) 650-1039

News Archive

Human Genome Sciences commences patient dosing in its HGS1029 inhibitor trial

Human Genome Sciences, Inc. and Aegera Therapeutics, Inc. today announced that HGS has initiated dosing in a Phase 1 clinical trial to evaluate the safety and tolerability of its lead IAP inhibitor, HGS1029, as monotherapy in patients with advanced lymphoid tumors.

New sunscreen ingredient that actively repairs sunburnt skin

People who suffer from sunburn could soon benefit from a new sunscreen ingredient that actively repairs sunburnt skin and helps prevent the onset of skin cancer, according to research published in the Journal of Investigative Dermatology.

Study evaluates potential risks and benefits of moderate alcohol consumption

A discussion by renowned epidemiologist Kenneth Mukamal has recently been published in the Journal of the American Medical Association, JAMA. It provides a discussion in response to a theoretical question, - if you are a 42 year old male, should you drink alcohol ( in moderation) for your health?

Study could help boost suicide prevention efforts in the U.S.

A study that could help to bolster suicide prevention efforts has examined the prevalence of suicidal ideation and suicide attempts among adults who reported psychotic experiences.

Preparing for future disasters 'saves lives, property and money'

In this post in USAID's "IMPACTblog," Kasey Channell, the acting director of the Disaster Response Team for USAID's Office of U.S. Foreign Disaster Assistance, reports on the importance of preparing for future disasters as the world observed International Day for Disaster Reduction on Thursday, writing Before the next disaster hits, now is the time to recommit to making smart investments that save lives, property, and money.

Barry S Levy, MD - Preventive Medicine in Sherborn, MA